查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2040685

睡眠輔助產品市場規模、佔有率和趨勢分析報告：按產品、疾病、分銷管道、地區和細分市場分類（2026-2033 年）

Sleep Aids Market Size, Share & Trends Analysis Report By Product (Medications, Sleep Therapy Devices), By Disorder (Insomnia, Obstructive Sleep Apnea, Narcolepsy, Parasomnias), By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

助眠劑市場概述

2025年全球助眠產品市場價值491億美元，預計2033年將達到952億美元，2026年至2033年的複合年成長率為8.7%。

失眠、睡眠呼吸中止症、不寧腿症候群等睡眠障礙的日益普遍是推動該產業發展的主要動力。

根據美國國家生物技術資訊中心（NCBI）2025年6月發表的報導，全球約有8.52億成年人患有失眠症，盛行率約16.2%。這項數據表明，有大量人群需要診斷和治療。

失眠仍然是最常見的睡眠障礙，原因包括焦慮、憂鬱症和睡眠週期不規則等。此外，睡眠呼吸中止症的盛行率不斷上升，而這種疾病與肥胖和心血管疾病密切相關，這推動了對持續性正壓呼吸器（CPAP）系統等醫療設備的需求。診斷率的提高和公眾意識的增強導致尋求治療的患者人數增加，進而帶動了對藥品、醫療設備和睡眠輔助產品整體產品的需求成長。

除了其高發病率外，它與心血管疾病和精神疾病等慢性疾病的關聯也推動了以下需求：

  • 處方安眠藥
  • 持續性呼吸道正壓通氣（CPAP）和用於治療睡眠呼吸中止症候群的醫療設備
  • 診斷和監測解決方案

此外，現代生活方式以高壓力、長時間工作和過度使用電子螢幕為特徵，顯著影響睡眠品質。快速的都市化和數位化擾亂了晝夜節律，導致入睡延遲和睡眠時間縮短。睡前大量使用智慧型手機和電子設備會抑制褪黑激素的分泌，進一步加劇睡眠障礙。因此，越來越多的消費者開始積極尋求解決方案，例如安眠藥、營養補充品和穿戴式睡眠設備。這種對主動睡眠管理的轉變正在加速臨床和消費級睡眠輔助產品的普及，從而支撐市場的持續成長。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：助眠產品市場：影響因素、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 睡眠輔助產品市場分析工具

第4章：助眠產品市場：產品具體估算與趨勢分析

  • 按產品分類的市場佔有率，2025 年和 2033 年
  • 全球助眠產品市場：依產品分類，展望
  • 製藥
  • 睡眠治療設備
    • 正壓通氣（PAP）裝置
    • 口內矯正器
    • 穿戴式睡眠追蹤器
  • 睡眠環境產品
  • 睡眠測試和診斷服務

第5章：助眠產品市場：疾病特異性估算與趨勢分析

  • 按疾病分類的市場佔有率（2025 年和 2033 年）
  • 全球助眠產品市場：依疾病分類，展望
  • 失眠
  • 阻塞型睡眠呼吸中止症（OSA）
  • 嗜睡症
  • 睡眠障礙（例如，夢遊、夜驚）
  • 不寧腿（RLS）
  • 其他

第6章：助眠產品市場：依分銷管道分類的估算與趨勢分析

  • 按分銷管道分類的市場佔有率，2025 年和 2033 年
  • 全球助眠產品市場：依通路分類，展望
  • 醫院藥房
  • 零售藥房
  • 電子商務平台
  • 藥局

第7章：助眠產品市場：區域估算與趨勢分析

  • 2025年及2033年區域市佔率分析
  • 區域市場概覽
  • 全球市場概述（按地區分類）
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第8章 競爭情勢

  • 公司和競爭對手的分類
  • 主要公司市佔率及市場狀況分析（2025 年）
  • 公司簡介
    • Merck & Co., Inc.
    • Pfizer Inc.
    • Sanofi SA
    • GSK plc
    • Takeda Pharmaceutical Company Limited
    • Teva Pharmaceutical Industries Ltd.
    • Koninklijke Philips NV
    • ResMed Inc.
    • Fisher & Paykel Healthcare Corporation Limited
    • Drive DeVilbiss Healthcare LLC
    • Compumedics Limited
    • Cadwell Industries, Inc.
    • Tempur World, LLC
Product Code: GVR-4-68040-890-7

Sleep Aids Market Summary

The global sleep aids market size was valued at USD 49.1 billion in 2025 and is projected to reach USD 95.2 billion by 2033, growing at a CAGR of 8.7% from 2026 to 2033. The increasing incidence of sleep disorders, including insomnia, sleep apnea, and restless leg syndrome, is a key factor driving the growth of the industry.

According to an article published in June 2025, under the National Center for Biotechnology Information, approximately 852 million adults globally suffer from insomnia, accounting for a global prevalence of around 16.2%, these data highlight the substantial patient population requiring diagnosis and treatment.

Insomnia remains the most common disorder, driven by factors such as anxiety, depression, and irregular sleep cycles. In addition, the growing prevalence of sleep apnea, closely linked to obesity and cardiovascular diseases, is increasing the demand for medical devices such as CPAP systems. As diagnosis rates improve and awareness increases, more patients are seeking treatment, thereby driving demand across pharmaceuticals, devices, and sleep-support products. This high disease

prevalence, combined with its association with chronic conditions such as cardiovascular diseases and mental health disorders, is driving demand for:

  • Prescription sleep medications
  • CPAP and sleep apnea devices
  • Diagnostic and monitoring solutions

In addition, modern lifestyle patterns, characterized by high stress, long working hours, and excessive screen exposure, are significantly contributing to poor sleep quality. Rapid urbanization and digitalization have disrupted circadian rhythms, leading to delayed sleep onset and reduced sleep duration. The widespread use of smartphones and digital devices before bedtime suppresses melatonin production, further aggravating sleep disorders. Therefore, a growing number of consumers are actively seeking solutions such as sleep medications, supplements, and wearable sleep technologies. This shift toward proactive sleep management is accelerating the adoption of both clinical and consumer sleep aids, thereby supporting sustained market growth.

Global Sleep Aids Market Report Segmentation

This report forecasts revenue growth at the global, regional & country levels and provides an analysis of the latest trends and opportunities in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global sleep aids market report on the basis of product, disorder, distribution channel, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Medications
  • Sleep Therapy Devices
    • Positive Airway Pressure (PAP) Devices
    • Oral Appliances
    • Wearable Sleep Trackers
  • Sleep Environment Products
  • Sleep Laboratory & Diagnostic Services
  • Disorder Outlook (Revenue, USD Million, 2021 - 2033)
  • Insomnia
  • Obstructive Sleep Apnea (OSA)
  • Narcolepsy
  • Parasomnias (e.g., Sleepwalking, Night Terrors)
  • Restless Legs Syndrome (RLS)
  • Other Sleep Disorders
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospital Pharmacies
  • Retail Pharmacies
  • E-Commerce Platforms
  • Drug Stores
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Norway
    • Denmark
    • Sweden
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Disorder
    • 1.1.3. Distribution Channel
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Sleep Aids Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Sleep Aids Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Sleep Aids Market: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2025 & 2033
  • 4.2. Segment Dashboard
  • 4.3. Global Sleep Aids Market by Product Outlook
  • 4.4. Medications
    • 4.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.5. Sleep Therapy Devices
    • 4.5.1. Positive Airway Pressure (PAP) Devices
      • 4.5.1.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 4.5.2. Oral Appliances
      • 4.5.2.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 4.5.3. Wearable Sleep Trackers
      • 4.5.3.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.6. Sleep Environment Products
    • 4.6.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.7. Sleep Laboratory & Diagnostic Services
    • 4.7.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 5. Sleep Aids Market: Disorder Estimates & Trend Analysis

  • 5.1. Disorder Market Share, 2025 & 2033
  • 5.2. Segment Dashboard
  • 5.3. Global Sleep Aids Market by Disorder Outlook
  • 5.4. Insomnia
    • 5.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 5.5. Obstructive Sleep Apnea (OSA)
    • 5.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 5.6. Narcolepsy
    • 5.6.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 5.7. Parasomnias (e.g., Sleepwalking, Night Terrors)
    • 5.7.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 5.8. Restless Legs Syndrome (RLS)
    • 5.8.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 5.9. Others
    • 5.9.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 6. Sleep Aids Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Distribution Channel Market Share, 2025 & 2033
  • 6.2. Segment Dashboard
  • 6.3. Global Sleep Aids Market by Distribution Channel Outlook
  • 6.4. Hospital Pharmacies
    • 6.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 6.5. Retail Pharmacies
    • 6.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 6.6. E-Commerce Platforms
    • 6.6.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 6.7. Drug Stores
    • 6.7.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 7. Sleep Aids Market: Regional Estimates & Trend Analysis, By product, By disorder, By Distribution Channel

  • 7.1. Regional Market Share Analysis, 2025 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2021 to 2033
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/ reimbursement structure
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework/ reimbursement structure
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework/ reimbursement structure
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework/ reimbursement structure
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework/ reimbursement structure
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework/ reimbursement structure
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework/ reimbursement structure
      • 7.7.6.3. Competitive scenario
      • 7.7.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework/ reimbursement structure
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework/ reimbursement structure
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Regulatory framework/ reimbursement structure
      • 7.9.1.3. Competitive scenario
      • 7.9.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework/ reimbursement structure
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework/ reimbursement structure
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework/ reimbursement structure
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Key company market share/position analysis, 2025
  • 8.3. Company Profiles
    • 8.3.1. Merck & Co., Inc.
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Product benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. Pfizer Inc.
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Product benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Sanofi S.A.
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Product benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. GSK plc
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Takeda Pharmaceutical Company Limited
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Teva Pharmaceutical Industries Ltd.
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Koninklijke Philips N.V.
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. ResMed Inc.
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Fisher & Paykel Healthcare Corporation Limited
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Drive DeVilbiss Healthcare LLC
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Compumedics Limited
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Cadwell Industries, Inc.
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Tempur World, LLC
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 List of secondary sources
  • Table 3 North America Sleep Aids Market, by country, 2021 - 2033 (USD Million)
  • Table 4 North America Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 5 North America Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 6 North America Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 7 U.S. Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 8 U.S. Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 9 U.S. Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 10 Canada Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 11 Canada Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 12 Canada Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 13 Mexico Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 14 Mexico Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 15 Mexico Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 16 Europe Sleep Aids Market, by country, 2021 - 2033 (USD Million)
  • Table 17 Europe Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 18 Europe Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 19 Europe Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 20 Germany Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 21 Germany Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 22 Germany Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 23 UK Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 24 UK Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 25 UK Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 26 France Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 27 France Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 28 France Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 29 Italy Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 30 Italy Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 31 Italy Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 32 Spain Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 33 Spain Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 34 Spain Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 35 Denmark Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 36 Denmark Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 37 Denmark Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 38 Sweden Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 39 Sweden Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 40 Sweden Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 41 Norway Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 42 Norway Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 43 Norway Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 44 Asia Pacific Sleep Aids Market, by country, 2021 - 2033 (USD Million)
  • Table 45 Asia Pacific Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 46 Asia Pacific Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 48 China Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 49 China Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 50 China Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 51 Japan Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 52 Japan Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 53 Japan Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 54 India Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 55 India Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 56 India Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 57 South Korea Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 58 South Korea Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 59 South Korea Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 60 Australia Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 61 Australia Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 62 Australia Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 63 Thailand Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 64 Thailand Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 65 Thailand Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 66 Latin America Sleep Aids Market, by country, 2021 - 2033 (USD Million)
  • Table 67 Latin America Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 68 Latin America Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 69 Latin America Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 70 Brazil Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 71 Brazil Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 72 Brazil Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 73 Argentina Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 74 Argentina Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 75 Argentina Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 76 MEA Sleep Aids Market, by country, 2021 - 2033 (USD Million)
  • Table 77 MEA Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 78 MEA Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 79 MEA Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 80 South Africa Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 81 South Africa Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 82 South Africa Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 83 Saudi Arabia Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 84 Saudi Arabia Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 85 Saudi Arabia Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 86 UAE Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 87 UAE Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 88 UAE Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 89 Kuwait Sleep Aids Market, by product, 2021 - 2033 (USD Million)
  • Table 90 Kuwait Sleep Aids Market, by disorder, 2021 - 2033 (USD Million)
  • Table 91 Kuwait Sleep Aids Market, by distribution channel, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Sleep Aids Market: market outlook
  • Fig. 9 Cryostat competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Sleep aids market driver impact
  • Fig. 15 Sleep aids market restraint impact
  • Fig. 16 Sleep aids market strategic initiatives analysis
  • Fig. 17 Sleep aids market: Product movement analysis
  • Fig. 18 Sleep aids market: Product outlook and key takeaways
  • Fig. 19 Medications market estimates and forecast, 2021 - 2033
  • Fig. 20 Sleep therapy devices market estimates and forecast, 2021 - 2033
  • Fig. 21 Positive airway pressure (PAP) Devices market estimates and forecast, 2021 - 2033
  • Fig. 22 Oral appliances market estimates and forecast, 2021 - 2033
  • Fig. 23 Wearable sleep trackers market estimates and forecast, 2021 - 2033
  • Fig. 24 Sleep environment products market estimates and forecast, 2021 - 2033
  • Fig. 25 Sleep laboratory & diagnostic services market estimates and forecast, 2021 - 2033
  • Fig. 26 Sleep aids market: Disorder movement analysis
  • Fig. 27 Sleep aids market: Disorder outlook and key takeaways
  • Fig. 28 Insomnia market estimates and forecast, 2021 - 2033
  • Fig. 29 Obstructive sleep apnea market estimates and forecast, 2021 - 2033
  • Fig. 30 Narcolepsy market estimates and forecast, 2021 - 2033
  • Fig. 31 Parasomnias market estimates and forecast, 2021 - 2033
  • Fig. 32 Restless legs syndrome market estimates and forecast, 2021 - 2033
  • Fig. 33 Other sleep disorder market estimates and forecast, 2021 - 2033
  • Fig. 34 Sleep Aids Market: Distribution Channel movement analysis
  • Fig. 35 Sleep Aids Market: Distribution Channel outlook and key takeaways
  • Fig. 36 Hospital Pharmacies market estimates and forecast, 2021 - 2033
  • Fig. 37 Retail Pharmacies market estimates and forecast, 2021 - 2033
  • Fig. 38 E-Commerce Platforms market estimates and forecast, 2021 - 2033
  • Fig. 39 Drug Store market estimates and forecast, 2021 - 2033
  • Fig. 40 Global Sleep Aids Market: Regional movement analysis
  • Fig. 41 Global Sleep Aids Market: Regional outlook and key takeaways
  • Fig. 42 Global Sleep Aids Market share and leading players
  • Fig. 43 North America market share and leading players
  • Fig. 44 Europe market share and leading players
  • Fig. 45 Asia Pacific market share and leading players
  • Fig. 46 Latin America market share and leading players
  • Fig. 47 Middle East & Africa market share and leading players
  • Fig. 48 North America: SWOT
  • Fig. 49 Europe SWOT
  • Fig. 50 Asia Pacific SWOT
  • Fig. 51 Latin America SWOT
  • Fig. 52 MEA SWOT
  • Fig. 53 North America, by country
  • Fig. 54 North America market estimates and forecasts, 2021 - 2033
  • Fig. 55 U.S. market estimates and forecasts, 2021 - 2033
  • Fig. 56 Canada market estimates and forecasts, 2021 - 2033
  • Fig. 57 Mexico market estimates and forecasts, 2021 - 2033
  • Fig. 58 Europe market estimates and forecasts, 2021 - 2033
  • Fig. 59 UK market estimates and forecasts, 2021 - 2033
  • Fig. 60 Germany market estimates and forecasts, 2021 - 2033
  • Fig. 61 France market estimates and forecasts, 2021 - 2033
  • Fig. 62 Italy market estimates and forecasts, 2021 - 2033
  • Fig. 63 Spain market estimates and forecasts, 2021 - 2033
  • Fig. 64 Denmark market estimates and forecasts, 2021 - 2033
  • Fig. 65 Sweden market estimates and forecasts, 2021 - 2033
  • Fig. 66 Norway market estimates and forecasts, 2021 - 2033
  • Fig. 67 Asia Pacific market estimates and forecasts, 2021 - 2033
  • Fig. 68 China market estimates and forecasts, 2021 - 2033
  • Fig. 69 Japan market estimates and forecasts, 2021 - 2033
  • Fig. 70 India market estimates and forecasts, 2021 - 2033
  • Fig. 71 South Korea market estimates and forecasts, 2021 - 2033
  • Fig. 72 Australia market estimates and forecasts, 2021 - 2033
  • Fig. 73 Thailand market estimates and forecasts, 2021 - 2033
  • Fig. 74 Latin America market estimates and forecasts, 2021 - 2033
  • Fig. 75 Brazil market estimates and forecasts, 2021 - 2033
  • Fig. 76 Argentina market estimates and forecasts, 2021 - 2033
  • Fig. 77 Middle East and Africa market estimates and forecasts, 2021 - 2033
  • Fig. 78 South Africa market estimates and forecasts, 2021 - 2033
  • Fig. 79 Saudi Arabia market estimates and forecasts, 2021 - 2033
  • Fig. 80 UAE market estimates and forecasts, 2021 - 2033
  • Fig. 81 Kuwait market estimates and forecasts, 2021 - 2033
  • Fig. 82 Market share of key market players- Sleep Aids Market